NO2 Power Blast
Natural health product licensed in Canada
- Other names
- Alpha XTRM, Black Label NO, NO2 Blast
- Licence holder
- Sloan Health Products, LLC
- NPN or DIN-HM
- 80069490
- Status
- Active licence
- Licence date
- 17 May 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque Source : Monohydrochlorure de L-arginine | 342.58 milligramme | Not calculated |
| Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque Source : Alpha-cétoglutarate de L-arginine | 342.58 milligramme | Not calculated |
| Malate de citrulline Source : Malate de citrulline | 83 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
L-arginine supports nitric oxide production. L-arginine is a non-essential amino acid that is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea).
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant, breastfeeding, have renal/kidney disease, or following a low protein diet. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners.
Source
Official Health Canada record, licence 80069490
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.